Related Experiment Video

Updated: Jun 23, 2025

Merkel Cell Polyomavirus Infection and Detection
13:45

Merkel Cell Polyomavirus Infection and Detection

Published on: February 7, 2019

9.9K

Merkel Cell Polyomavirus targets SET/PP2A complex to promote cellular proliferation and migration

Purnima Gupta1, Assunta Venuti1, Michelle Savoldy2

  • 1International Agency for Research on Cancer, Lyon, France.

Virology
|June 25, 2024
PubMed

Insights

Researchers identified the SET protein as a key regulator in Merkel Cell Carcinoma (MCC), a rare skin cancer. Targeting SET protein shows promise for developing new MCC treatments by inhibiting tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Merkel Cell Carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer.
  • Previous research identified NDRG1 as crucial for inhibiting MCC cell proliferation and migration.
  • The role of genes modulated by the Merkel cell polyomavirus (MCPyV) early genes in MCC requires further elucidation.

Purpose of the Study:

  • To investigate the upstream regulators of NDRG1 modulated by MCPyV early genes in MCC.
  • To explore the therapeutic potential of targeting the SET protein in MCC treatment.

Main Methods:

  • Investigated SET protein expression in MCC cell lines (hTERT-HK-MCPyV and MCPyV+) and tumor tissues.
  • Utilized the small molecule inhibitor FTY720 to disrupt the SET-PP2A interaction.
  • Employed short hairpin RNA (shRNA) for SET inhibition.
  • Assessed cell proliferation, migration, cell cycle regulators (cyclinD1, CDK2), and colony formation.

Main Results:

  • Identified SET protein (intrinsic inhibitor of PP2A) as being modulated by MCPyV early genes and upstream of NDRG1 in MCC.
  • Strong SET expression was observed in MCC dermal tumor tissues.
  • Inhibition of SET-PP2A interaction using FTY720 increased NDRG1 expression and suppressed cell cycle regulators (cyclinD1, CDK2) in hTERT-HK-MCPyV cells.
  • SET inhibition via shRNA and FTY720 significantly decreased cell proliferation and colony formation in MCPyV+ MCC cells.

Conclusions:

  • The SET protein plays a significant role in MCC pathogenesis by modulating NDRG1 and influencing cell proliferation.
  • Targeting the SET-PP2A interaction presents a potential therapeutic strategy for Merkel Cell Carcinoma.
  • Drugs targeting the SET protein could offer a novel treatment approach for MCC patients.
Keywords:
FTY720Merkel Cell PolyomavirusNDRG1PP2ASET

More Related Videos

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

14.9K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K